An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

UnknownOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

August 8, 2022

Study Completion Date

September 15, 2022

Conditions
Fungal InfectionOnychomycosisTinea Unguium
Interventions
DRUG

CGB-400 Topical Gel

CGB-400 Gel contains two main ingredients: geranic acid and choline. Geranic acid, a naturally occurring essential oil/terpenoid, is a key ingredient in lemon grass and is also found in other natural materials such as cardamom. The other main ingredient in CAGE is choline, which is an essential dietary component and found in foods as free choline and as several esterified forms such as phosphocholine and phosphatidylcholine.

Trial Locations (1)

76104

RECRUITING

John Peter Smith Hospital, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

John Peter Smith Hospital

UNKNOWN

lead

CAGE Bio Inc.

INDUSTRY

NCT05202366 - An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection | Biotech Hunter | Biotech Hunter